What is the main concern with iodine-based contrast in CT scans?

What is the main concern with iodine-based contrast in CT scans?

• A. It can be hard on the kidneys, especially in patients with low kidney function
• B. It causes hair loss
• C. It has no effect on kidneys
• D. It can be hard on the kidneys, especially in patients with high kidney function

Answer: (D)

The main concern with iodine-based contrast is the potential for kidney injury after its use. This is called contrast-induced nephropathy or contrast-associated acute kidney injury. The contrast material can cause two harmful effects in the kidneys: it can directly damage renal tubular cells and it can cause blood vessels in the kidney to constrict, reducing blood flow and the filtering ability (glomular filtration rate). As a result, kidney function can worsen, usually showing up as a rise in serum creatinine within about 24 to 72 hours after the scan. The risk is greatest in people who already have reduced kidney function (lower GFR), as well as those who are dehydrated, older, have diabetes, heart failure, or are taking other nephrotoxic drugs. It’s not a problem that’s tied to having high kidney function; in fact, those with healthy kidneys are at much lower risk. To minimize risk, clinicians check kidney function beforehand (eGFR), ensure proper hydration around the procedure, use the smallest effective contrast dose, and choose lower-risk contrast options when possible. If kidney function is severely impaired, alternatives or delaying the contrast-enhanced study may be considered.

The main concern with iodine-based contrast is the potential for kidney injury after its use. This is called contrast-induced nephropathy or contrast-associated acute kidney injury. The contrast material can cause two harmful effects in the kidneys: it can directly damage renal tubular cells and it can cause blood vessels in the kidney to constrict, reducing blood flow and the filtering ability (glomular filtration rate). As a result, kidney function can worsen, usually showing up as a rise in serum creatinine within about 24 to 72 hours after the scan.

The risk is greatest in people who already have reduced kidney function (lower GFR), as well as those who are dehydrated, older, have diabetes, heart failure, or are taking other nephrotoxic drugs. It’s not a problem that’s tied to having high kidney function; in fact, those with healthy kidneys are at much lower risk.

To minimize risk, clinicians check kidney function beforehand (eGFR), ensure proper hydration around the procedure, use the smallest effective contrast dose, and choose lower-risk contrast options when possible. If kidney function is severely impaired, alternatives or delaying the contrast-enhanced study may be considered.